Literature DB >> 8809470

Tumor necrosis factor: function, release and clearance.

M H Bemelmans1, L J van Tits, W A Buurman.   

Abstract

Tumor Necrosis Factor (TNF) is a multifunctional cytokine. It plays an important role in the pathophysiology of several diseases. Recently, it has been discovered that TNF is circulating in two different forms, a bioactive form and an immunologically detectable form. These two forms of TNF show different clearance kinetics. The immunological form is supposed to be an inactivated TNF protein. For this inactivation, proteolytic degradation or TNF binding by inactivating proteins is necessary. In this review we have focused on TNF inactivation by TNF binding proteins. Recent data show that there are soluble TNF receptors circulating which can bind and inactivate TNF. These receptors are membrane-bound TNF receptors which have been proteolytically cleaved from the cell membrane. Two TNF receptors are circulating, the soluble TNF receptor of 55 kDa (P55) and the receptor of 75 kDa (P75). The receptors are held responsible not only for inactivation of the TNF, but also for the clearance of TNF. Recent data show that the kidney is the most important organ for TNF clearance, followed by the liver. All other organs are of less importance. In this review, function, release, and clearance of TNF are discussed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8809470     DOI: 10.1615/critrevimmunol.v16.i1.10

Source DB:  PubMed          Journal:  Crit Rev Immunol        ISSN: 1040-8401            Impact factor:   2.214


  33 in total

Review 1.  Idiosyncratic drug-induced liver injury and the role of inflammatory stress with an emphasis on an animal model of trovafloxacin hepatotoxicity.

Authors:  Patrick J Shaw; Patricia E Ganey; Robert A Roth
Journal:  Toxicol Sci       Date:  2010-06-10       Impact factor: 4.849

2.  Cardiovascular dysfunction in burns: review of the literature.

Authors:  G S Abu-Sittah; K A Sarhane; S A Dibo; A Ibrahim
Journal:  Ann Burns Fire Disasters       Date:  2012-03-31

Review 3.  TNF-α, a good or bad factor in hematological diseases?

Authors:  Tian Tian; Min Wang; Daoxin Ma
Journal:  Stem Cell Investig       Date:  2014-06-01

Review 4.  Novel biomarkers for the progression of diabetic nephropathy: soluble TNF receptors.

Authors:  Tomohito Gohda; Yasuhiko Tomino
Journal:  Curr Diab Rep       Date:  2013-08       Impact factor: 4.810

5.  Kidney Dysfunction and Markers of Inflammation in the Multicenter AIDS Cohort Study.

Authors:  Alison G Abraham; Annie Darilay; Heather McKay; Joseph B Margolick; Michelle M Estrella; Frank J Palella; Robert Bolan; Charles R Rinaldo; Lisa P Jacobson
Journal:  J Infect Dis       Date:  2015-03-11       Impact factor: 5.226

6.  Dendritic cells serve as a "Trojan horse" for oncolytic adenovirus delivery in the treatment of mouse prostate cancer.

Authors:  Zhao-Lun Li; Xuan Liang; He-Cheng Li; Zi-Ming Wang; Tie Chong
Journal:  Acta Pharmacol Sin       Date:  2016-06-27       Impact factor: 6.150

7.  The determinants for the enzyme activity of human parvovirus B19 phospholipase A2 (PLA2) and its influence on cultured cells.

Authors:  Xuefeng Deng; Yanming Dong; Qianhui Yi; Yu Huang; Dan Zhao; Yongbo Yang; Peter Tijssen; Jianming Qiu; Kaiyu Liu; Yi Li
Journal:  PLoS One       Date:  2013-04-15       Impact factor: 3.240

8.  Trovafloxacin enhances TNF-induced inflammatory stress and cell death signaling and reduces TNF clearance in a murine model of idiosyncratic hepatotoxicity.

Authors:  Patrick J Shaw; Kevin M Beggs; Erica M Sparkenbaugh; Christine M Dugan; Patricia E Ganey; Robert A Roth
Journal:  Toxicol Sci       Date:  2009-07-28       Impact factor: 4.849

9.  Serum interleukin-6 and interleukin-8 are early biomarkers of acute kidney injury and predict prolonged mechanical ventilation in children undergoing cardiac surgery: a case-control study.

Authors:  Kathleen D Liu; Christopher Altmann; Gerard Smits; Catherine D Krawczeski; Charles L Edelstein; Prasad Devarajan; Sarah Faubel
Journal:  Crit Care       Date:  2009-07-01       Impact factor: 9.097

Review 10.  Mononuclear phagocytes in head and neck squamous cell carcinoma.

Authors:  Kenneth Wilfried Kross; John-Helge Heimdal; Hans Jørgen Aarstad
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-12-05       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.